NEW STUDY: published in European Urology Oncology suggests potential opportunities to reshape how patients with nonmetastatic prostate cancer are treated. Researchers conducted the largest whole-transcriptome analysis of nonmetastatic prostate cancer known to date—evaluating over

sciencedirect.com/science/articl…

Genomic classifier #Decipher® guides treatment intensification in post-prostatectomy patients. Phuoc T. Tran University of Maryland School of Medicine joins Angela Jia RadOncUH to discuss findings from the RTOG 0534 #SPPORT trial examining the Decipher® genomic classifier scores as predictors of treatment

Thanks Sophia Kamran, MD & Constantinos Zamboglou for this invitation to highlight keypoints and thoughts about ADT and Post-op RT. sciencedirect.com/science/articl… ✨✨✨✨✨✨✨✨✨✨

Combining genomic classifier and digital pathology #ArtificialIntelligence in #ProstateCancer risk stratification. Daniel E Spratt Case Comp Cancer Ctr joins Zach Klaassen Georgia Cancer Center discuss a study of nearly 10,000 #ProstateCancer patients comparing the 22-gene Decipher® genomic

Happy to join Elizabeth Plimack MD and UroToday.com in this discussion on our #SURE02 trial and on newer bladder-sparing approaches Chiara Mercinelli Valentina Tateo Antonio Cigliola Brigida Maiorano ASCO Ospedale San Raffaele Università Vita-Salute San Raffaele Elai Davicioni Joep J. de Jong Veracyte, Inc. Foundation Medicine Fondazione AIRC per la ricerca sul cancro associazionepalinuro

SURE-02: Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab, Response-Adapted Bladder Sparing, and Adjuvant Pembrolizumab for Patients With MIBC guoncologynow.com/post/sure-02-n…

Postoperative Radiation and Hormonal Therapy in the Management of Prostate Cancer - Paul Sargos Paul Sargos Sophia Kamran, MD Constantinos Zamboglou oncodaily.com/blog/paul-sarg… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #ProstateCancer

Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 Men | JCO Precision Oncology ascopubs.org/doi/10.1200/PO… nice work RadOncUH Angela Jia

Nice work from NM Urology team onlinelibrary.wiley.com/share/I8V6CVPX…

In the search for newer immunotherapy-Response biomarkers in muscle-invasive #bladdercancer we could have ER and AR expression. ER signature expression was associated with poorer outcome in #PURE01 trial. Hints for studies with novel ER inhibitors in MIBC. Congrats Valentina Tateo &

Important TiP: TRIPLE SWITCH RCT for adding docetaxel to mHSPC patients that don't reach PSA <0.2 on doublet treatment intensification UroToday.com

NEW DATA: Real-world analysis of over 250K thyroid nodule fine needle aspiration (FNA) samples were presented at #ITC2025 revealing insights into the genomic landscape of medullary thyroid cancer (MTC), a rare but aggressive form of thyroid disease. | STUDY OVERVIEW |

🚨What's in a name? Why differentiation between biochemical recurrence and metastatic #prostatecancer matters 👏 New review led by Anael Rizzo David Geffen School of Medicine at UCLA & Pratik Kanabur UCLA Urology 👉Differentiating BCR & metastatic risk groups is 🔑 to help personalize care for our patients

Genomic Classifier Decipher® guides treatment intensification in post-prostatectomy patients. Phuoc Tran, MD, PhD University of Maryland School of Medicine joins Angela Jia RadOncUH to discuss findings from the RTOG 0534 #SPPORT trial examining Decipher® genomic classifier scores as predictors of

Molecular characterization of residual muscle-invasive bladder cancer identifies a scar-like transcriptomicprofile with favorable prognosis after neoadjuvant therapy aacrjournals.org/clincancerres/… nice work Joep J. de Jong Ewan Gibbs

Another great pod ⁦ podcasts.apple.com/it/podcast/hea…

A study of 140K+ men with nonmetastatic #ProstateCancer showed that over 60% with high Decipher scores (>0.85) and AJCC grade IIC–IIIC may benefit from targeted therapies. Findings support #DecipherProstate by Veracyte, Inc. testing to guide personalized treatment.